The Cancer of the Pancreas Screening-5 CAPS5)Study

The Cancer of the Pancreas Screening-5 CAPS5)Study is a phase 3, interventional study registered as NCT02000089 by Johns Hopkins University, with a registry enrolment figure of 9000 participants, started 2014-01-06 and due to reach its primary completion in 2028-12. Interventions recorded: Secretin; MRI; Tumor marker gene test with CA19-9. Conditions listed: Pancreas Cancer; Peutz-Jeghers Syndrome (PJS); Gene Mutation; Germline Mutation Carrier; Lynch Syndrome. Primary outcome: Evaluate pancreatic juice for early cancer markers.. Pancreatic eligibility wording from the registry: "* Hereditary Pancreatitis or". Sites: United States. No results are recorded here; the registry entry is the source.